1 / 5

FDA Advisory Committee for Lotronex

FDA Advisory Committee for Lotronex. Jeffrey D. Roberts, B.Sc. President & Founder Irritable Bowel Syndrome Self Help Group, Irritable Bowel Syndrome Association, Coordinator Lotronex Action Group jeffrey.roberts@ibsgroup.org http://www.ibsgroup.org. Side Effects while taking Lotronex.

bhuggins
Download Presentation

FDA Advisory Committee for Lotronex

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FDA Advisory Committee for Lotronex Jeffrey D. Roberts, B.Sc. President & Founder Irritable Bowel Syndrome Self Help Group, Irritable Bowel Syndrome Association, Coordinator Lotronex Action Group jeffrey.roberts@ibsgroup.org http://www.ibsgroup.org

  2. Side Effects while taking Lotronex Diarrhea 2% Constipation 25% Ischemic Colitis 1% Nausea 3% None 59% Abdominal Pain 6% Sleep Disturb. 1% Other 3% Patients’ Perspective References: Electronic survey conducted by the Irritable Bowel Syndrome Self Help Group December 2000 – March 2001 of 485 former and current Lotronex users.

  3. Restrictions Willing to Accept Reference: Electronic survey conducted by the Irritable Bowel Syndrome Self Help Group March 2002 – April 2002 of IBS sufferers.

  4. Risk Management • Patients sign an Informed Consent form • Patients participate in surveys about use and side effects in order to provide ongoing feedback • IBS Self Help Group and IBS Association websites1 provide Lotronex education and signs and symptoms information to users and the IBS Community Reference:1. http://www.ibsgroup.org and http://www.ibsassociation.org

  5. Conclusion • IBS sufferer’s quality of life was dramatically improved with access to Lotronex. • IBS sufferers are prepared to accept the risks associated with its use. • IBS sufferers will work with the FDA to reduce those risks.

More Related